Results 41 to 50 of about 357,658 (278)

Scaling of transverse nuclear magnetic relaxation due to magnetic nanoparticle aggregation [PDF]

, 2010
The aggregation of superparamagnetic iron oxide (SPIO) nanoparticles decreases the transverse nuclear magnetic resonance (NMR) relaxation time T2 of adjacent water molecules measured by a Carr-Purcell-Meiboom-Gill (CPMG) pulse-echo sequence.
Berezovsky, J., Brown, K. A., Cima, M. J., Issadore, D., Vassiliou, C. C., Westervelt, R. M.   +5 more
core   +3 more sources

Preparation of magnetic mesoporous silica nanoparticles as a multifunctional platform for potential drug delivery and hyperthermia

Science and Technology of Advanced Materials, 2016
We report the preparation of magnetic mesoporous silica (MMS) nanoparticles with the potential multifunctionality of drug delivery and magnetic hyperthermia. Carbon-encapsulated magnetic colloidal nanoparticles (MCN@C) were used to coat mesoporous silica
Xia Yu, Yufang Zhu
doaj   +1 more source

Sonochemical Modification of the Superconducting Properties of MgB2

, 2003
Ultrasonic irradiation of magnesium diboride slurries in decalin produces material with significant inter-grain fusion. Sonication in the presence of Fe(CO)5 produces magnetic Fe2O3 nanoparticles embedded in the MgB2 bulk.
Alexey Snezhko, Kenneth S. Suslick, Ruslan Prozorov, Tanya Prozorov, Wang Y.-S.   +4 more
core   +1 more source

Magnetic Nanoparticles for Application in Nanomedicine

Communications, 2010
This contribution will summarize the information about the ways of synthesizing biocompatible magnetic nanoparticles and complexes containing them and the possibility of their application in nanomedicine at magnetic drug targeting and thermal treatment ...
Milan Timko, Peter Kopcansky, M. Koneracka, Vlasta Zavisova, N. Tomasovicova, A. Dzarova   +5 more
doaj   +1 more source

Modification of human monocytes and macrophages by magnetic nanoparticles in vitro for cell-based delivery

Бюллетень сибирской медицины, 2021
The aim of the study was to develop a method for the modification of human monocytes/macrophages by iron oxide magnetic nanoparticles in vitro.Materials and methods.
N. A. Perekucha, P. A. Smolina, A. M. Demin, V. P. Krasnov, A. G. Pershina   +4 more
doaj   +1 more source

Dipolar interaction effects in the thermally activated magnetic relaxation of two-dimensional nanoparticle ensembles [PDF]

, 2003
The thermally activated magnetic relaxation in two-dimensional ensembles of dipolar interacting nanoparticles with large uniaxial perpendicular anisotropy is studied by a numerical method and within the mean-field approximation.
Denysov, Stanislav Ivanovych, Liutyi, Taras Volodymyrovych, Trohidou, K.N., Денисов, Станислав Иванович, Денисов, Станіслав Іванович, Лютий, Тарас Володимирович, Лютый, Тарас Владимирович   +6 more
core   +2 more sources

Magnetic Nanoparticles

, 2004
Solicitantes: Consejo Superior de Investigaciones Científicas y Midatech. Limited Nº internacional de solicitud: PCT/GB2004/002408 Fecha internacional de solicitud: 07.06.2004 Clasificación internacional: A61K 47/48 (2006.01), A61K 49/18 (2006.01), A61K 9/50 (2006.01) [EN] Materials and methods for making small magnetic particles, e.g.
J Harrell, David Nikles
openaire   +3 more sources

Recent Advances in the Application of Magnetic Nanoparticles as a Support for Homogeneous Catalysts

Nanomaterials, 2014
Magnetic nanoparticles are a highly valuable substrate for the attachment of homogeneous inorganic and organic containing catalysts. This review deals with the very recent main advances in the development of various nanocatalytic systems by the ...
Joseph Govan, Yurii K. Gun'ko
doaj   +1 more source

Antiferromagnetic Order in MnO Spherical Nanoparticles [PDF]

, 2011
We have performed unpolarized and polarized neutron diffraction experiments on monodisperse 8 nm and 13 nm antiferromagnetic MnO nanoparticles. For the 8 nm sample, the antiferromagnetic transition temperature $T_N$ (114 K) is suppressed compared to the ...
A. D. Christianson, C. H. Wang, D. U. Lee, G. A. Baker, L. M. D. Cranswick, M. D. Lumsden, P. D. Deen, S. E. Nagler, S. N. Baker, T. Chatterji, W. T. Heller, Y. Su   +11 more
core   +2 more sources

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source